Skip to the page

Data / Form D filings / ASCENDIA PHARMACEUTICALS, INC.

ASCENDIA PHARMACEUTICALS, INC.: Form D filings

ASCENDIA PHARMACEUTICALS, INC., a health care company in North Brunswick, NJ, filed 5 Form D notices with the SEC between 2021 and 2026. The latest, on July 24, 2026, reports $4.1 million sold of a $4.1 million offering to 3 investors.

SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.

Company details from the filing

Address
661 US HIGHWAY ONE UNIT B, North Brunswick, NJ, 08902
Phone
(732) 640-0058
Industry
Other Health Care
Entity type
Corporation
Incorporated in
Delaware
Revenue range
Decline to Disclose
Exemptions claimed
Rule 506(b)
SEC identifier (CIK)
1855888

Form D filings

FiledTypeOfferingSoldRemainingInvestorsFirst saleFiling
Jul 24, 2026New notice$4,084,536$4,084,5363Jun 26, 2026sec.gov
Jun 4, 2025New notice$2,500,000$2,500,0009May 22, 2025sec.gov
Oct 11, 2024New notice$2,500,638$2,500,6382Sep 30, 2024sec.gov
Jul 13, 2022New notice$2,499,945$2,499,9452Jul 1, 2022sec.gov
Apr 20, 2021New notice$9,999,999$4,999,999$5,000,0002Apr 7, 2021sec.gov

Executive officers and directors named in the filing

NameRoleNote in the filing
Jingjun HuangDirector
Michael BogdaDirector
James GaleDirector
Robert BloderDirector
Theron OdlaugDirector
Shoufeng LiDirector

Other health care companies in New Jersey that filed recently

Every Form D from the week of Jul 20, 2026 · All recent filings in New Jersey · All recent Other Health Care filings

Read from SEC EDGAR. Amount sold is what ASCENDIA PHARMACEUTICALS, INC. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.